Wednesday's Mid-Day Movers: Celator Pharmaceuticals, Box, MeetMe, Himax, And More

Wednesday contained many notable movers:

Winners

Celator Pharmaceuticals Inc (NASDAQ: CPXX) - Was up 29 percent after announcing positive induction response results from a Phase 3 Study of CPX-351 in patients who suffer with high-risk Myeloid Leukemia. According to the press release, results showed that the CPX-351 produced an improvement in “induction response rate of 43.2 percent.”

MeetMe Inc (NASDAQ: MEET) - Was up 23 percent on a better than expected second quarter guidance; The social network company raised revenue alongside EBITDA guidance. MeetMe expects sales of $10.5-$10.7 million, up from previous expectations of $9-$9.5 million. Adjusted EBITDA is expected to fall in the range of $1.5-$2 million, up significantly from previous $250,000-$750,000.

Geospace Technologies Corporation (NASDAQ: GEOS) - Was up 12.5 percent. The tech company spiked on positive analyst ratings and price targets, most of which were bullish, giving the company price targets in the range of $25-$40.

Synthesis Energy Systems Inc (NASDAQ: SYMX) - Was up 12 percent on Elite Investment’s article on Synthesis, stating that the stock is “ready for eruption” as well as reiterating John Paulson’s buying of 10 million shares of the stock in April.

Box Inc (NYSE: BOX) - Was up 7 percent. Box struck a deal to partner with IBM to combine new cloud-based services and products in hopes to develop new services.

Lennar Corporation (NYSE: LEN) - Was up 5 percent. The stock was up due to an earnings beat by $0.14, at $0.79 per share. Revenue also topped analyst forecasts; the home builder reported sales of $2.39 billion versus analyst expectations of $2.02 billion.

Sysco Corporation (NYSE: SYY) - Was up 4 percent. The North American food distributor was denied takeover of US Foods by a federal judge; The judge claimed the acquisition would reduce competition alongside lead to spiked prices in the hotel and restaurant industry. Sysco may either choose to appeal or drop the deal.

Freeport-McMoRan Inc (NYSE: FCX) - Was up 4.6 percent. The natural resource company’s Freeport-McMoRan Oil & Gas unit filed for an IPO of common shares up to $100 million. Freeport plans to list on the NYSE with the ticker “FMOG.”

Netflix Inc (NASDAQ: NFLX) - Was up 3.2 percent. As it approaches a new all-time high, Netflix announced a stock split, seven-for-one, that will be payable on the 14th of July to shareholders on record at the close of July 2nd. The split will give investors an opportunity to buy the growing stock at a cheaper price.

Losers

Transition Therapeutics Inc (NASDAQ: TTHI) - Was down 72 percent after reporting that its Phase ⅔ clinical study of drug ELND005 was disappointing and did not meet the company’s primary endpoint. The company notes that analysis of the full study dataset will still be further performed.

Alcobra Ltd (NASDAQ: ADHD) - Was down 13 percent after its generic disorder drug fails a mid-stage trial. The company failed to treat Fragile X Syndrome, a disorder that may cause autism.

Fitbit Inc (NYSE: FIT) - Was down 7 percent, first decline since its IPO, after Global Equities Research analyst Trip Chowdhry recommended fundamental investors to “take profits” on the wearable technology company. He also noted that the company appears to be declining in assets.

Inphi Corporation (NYSE: IPHI) - Was down 6 percent on a downgrade from Northland Capital.

Himax Technologies Inc (NASDAQ: HIMX) - Was down 5.2 percent, after surging yesterday, on high volume trading. Himax was trading 2.86 times the normal volume on Wednesday.